Inventor · disambiguated record
Gideon Bollag
Also filed as: BOLLAG GIDEON
11 granted patents·10 pending applications·660 citations·filing 1998–2017
94Inventor score
Top patents by PatentIndex Score
21 records- 0198US9550768B2Kinase modulation and indications thereforPLEXXIKON INC·Filed 2013·Granted Jan 24, 2017·41 cites·6 claims
- 0298US8470818B2Compounds and methods for kinase modulation, and indications thereforIBRAHIM PRABHA N·Filed 2010·Granted Jun 25, 2013·94 cites·56 claims
- 0398US8415469B2Compounds and methods for kinase modulation, and indications thereforIBRAHIM PRABHA N·Filed 2009·Granted Apr 9, 2013·84 cites·18 claims
- 0498US8143271B2Compounds and methods for kinase modulation, and indications thereforIBRAHIM PRABHA N·Filed 2011·Granted Mar 27, 2012·124 cites·8 claims
- 0598US7863288B2Compounds and methods for kinase modulation, and indications thereforPLEXXIKON INC·Filed 2006·Granted Jan 4, 2011·187 cites·54 claims
- 0697US9730918B2Kinase modulation, and indications thereforPLEXXIKON INC·Filed 2016·Granted Aug 15, 2017·25 cites·3 claims
- 0797US9358235B2Kinase modulation, and indications thereforPLEXXIKON INC·Filed 2013·Granted Jun 7, 2016·41 cites·3 claims
- 0895US9814714B2Kinase modulation, and indications thereforPLEXXIKON INC·Filed 2016·Granted Nov 14, 2017·22 cites·31 claims
- 0992US10123998B2Kinase modulation, and indications thereforPLEXXIKON INC·Filed 2017·Granted Nov 13, 2018·9 cites·13 claims
- 1088US7307071B2RAF-MEK-ERK pathway inhibitors to treat cancerONYX PHARMA INC·Filed 2002·Granted Dec 11, 2007·31 cites·8 claims
- 1165US2018111929A1Compounds and methods for kinase modulation, and indications thereforPLEXXIKON INC·Filed 2017·Application pending·0 cites
- 1265US2013261117A1Compounds and methods for kinase modulation, and indications thereforPLEXXIKON INC·Filed 2013·Application pending·0 cites
- 1363US2013303534A1Compounds and methods for kinase modulation, and indications thereforPLEXXIKON INC·Filed 2013·Application pending·0 cites
- 1460US2016176865A1Compounds and methods for kinase modulation, and indications thereforPLEXXIKON INC·Filed 2015·Application pending·0 cites
- 1560US2012053177A1Compounds and methods for kinase modulation, and indications thereforIBRAHIM PRABHA N·Filed 2011·Application pending·0 cites
- 1658US2005048573A1PDE5A crystal structure and usesPLEXXIKON INC·Filed 2004·Application pending·0 cites
- 1758US2015290205A1Compounds and methods for kinase modulation, and indications thereforPLEXXIKON INC·Filed 2015·Application pending·0 cites
- 1844US2003203464A1Methods and compositions for treating abnormal cell growth related to unwanted guanine nucleotide exchange factor activityFiled 2002·Application pending·0 cites
- 1941US2005079548A1Ligand development using PDE4B crystal structuresPLEXXIKON INC·Filed 2004·Application pending·0 cites
- 2035US6340575B1Methods and compositions for treating abnormal cell growth related to unwanted guanine nucleotide exchange factor activityONYX PHARMA INC·Filed 1998·Granted Jan 22, 2002·2 cites·15 claims
- 2127US2003013181A1Novel nucleic acids and polypeptides related to a farnesyl-directed endopeptidaseFiled 1999·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →